BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 38435861)

  • 21. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.
    de Sanjose S; Benavente Y; Vajdic CM; Engels EA; Morton LM; Bracci PM; Spinelli JJ; Zheng T; Zhang Y; Franceschi S; Talamini R; Holly EA; Grulich AE; Cerhan JR; Hartge P; Cozen W; Boffetta P; Brennan P; Maynadié M; Cocco P; Bosch R; Foretova L; Staines A; Becker N; Nieters A
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):451-8. PubMed ID: 18387498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients.
    Morton LM; Landgren O; Chatterjee N; Castenson D; Parsons R; Hoover RN; Engels EA
    Blood; 2007 Dec; 110(13):4599-605. PubMed ID: 17855632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer risk following organ transplantation: a nationwide cohort study in Sweden.
    Adami J; Gäbel H; Lindelöf B; Ekström K; Rydh B; Glimelius B; Ekbom A; Adami HO; Granath F
    Br J Cancer; 2003 Oct; 89(7):1221-7. PubMed ID: 14520450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma.
    Kapelushnik J; Ariad S; Benharroch D; Landau D; Moser A; Delsol G; Brousset P
    Br J Haematol; 2001 May; 113(2):425-8. PubMed ID: 11380409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8.
    Dotti G; Fiocchi R; Motta T; Facchinetti B; Chiodini B; Borleri GM; Gavazzeni G; Barbui T; Rambaldi A
    Leukemia; 1999 May; 13(5):664-70. PubMed ID: 10374868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.
    Lucas KG; Small TN; Heller G; Dupont B; O'Reilly RJ
    Blood; 1996 Mar; 87(6):2594-603. PubMed ID: 8630428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients.
    Opelz G; Henderson R
    Lancet; 1993 Dec 18-25; 342(8886-8887):1514-6. PubMed ID: 7902900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-alpha-induced acute renal allograft rejection.
    Magnone M; Holley JL; Shapiro R; Scantlebury V; McCauley J; Jordan M; Vivas C; Starzl T; Johnson JP
    Transplantation; 1995 Apr; 59(7):1068-70. PubMed ID: 7709447
    [No Abstract]   [Full Text] [Related]  

  • 29. Pretransplantation assessment of the risk of lymphoproliferative disorder.
    Walker RC; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; McGregor CG; Paya CV
    Clin Infect Dis; 1995 May; 20(5):1346-53. PubMed ID: 7620022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Case of Epstein-Barr Virus-Negative Post-transplant Lymphoproliferative Disorder in a Solid Organ Transplant Recipient With Untreated Chronic Hepatitis C.
    Asiimwe E; Mead M
    Cureus; 2024 Jan; 16(1):e53323. PubMed ID: 38435861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R; Comoli P; Caillard S; Moulin B; Hirsch HH; Meylan P;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
    Mentzer SJ; Perrine SP; Faller DV
    Transpl Infect Dis; 2001 Sep; 3(3):177-85. PubMed ID: 11493400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The IPTA Nashville Consensus Conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: III - Consensus guidelines for Epstein-Barr virus load and other biomarker monitoring.
    Preiksaitis J; Allen U; Bollard CM; Dharnidharka VR; Dulek DE; Green M; Martinez OM; Metes DM; Michaels MG; Smets F; Chinnock RE; Comoli P; Danziger-Isakov L; Dipchand AI; Esquivel CO; Ferry JA; Gross TG; Hayashi RJ; Höcker B; L'Huillier AG; Marks SD; Mazariegos GV; Squires J; Swerdlow SH; Trappe RU; Visner G; Webber SA; Wilkinson JD; Maecker-Kolhoff B
    Pediatr Transplant; 2024 Feb; 28(1):e14471. PubMed ID: 37294621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-transplant lymphoproliferative disease after pediatric kidney transplant.
    Fulchiero R; Amaral S
    Front Pediatr; 2022; 10():1087864. PubMed ID: 36568415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies.
    Davis JE; Moss DJ
    Tissue Antigens; 2004 Apr; 63(4):285-92. PubMed ID: 15009802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying the patient at risk for post-transplant lymphoproliferative disorder.
    Cockfield SM
    Transpl Infect Dis; 2001 Jun; 3(2):70-8. PubMed ID: 11395972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological Difference Between Epstein-Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact.
    Ferla V; Rossi FG; Goldaniga MC; Baldini L
    Front Oncol; 2020; 10():506. PubMed ID: 32457824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Associated with Post-Transplant Active Epstein-Barr Virus Infection and Lymphoproliferative Disease in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis.
    Enok Bonong PR; Zahreddine M; Buteau C; Duval M; Laporte L; Lacroix J; Alfieri C; Trottier H
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33808928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus-associated smooth muscle tumors after lung transplantation.
    Hirama T; Tikkanen J; Pal P; Cleary S; Binnie M
    Transpl Infect Dis; 2019 Jun; 21(3):e13068. PubMed ID: 30864272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term remission in an adult heart transplant recipient with advanced Burkitt's lymphoma post-transplant lymphoproliferative disorder after anthracycline-free chemotherapy: A case report and literature review.
    AbdelHameid D; Felice A; Cooper LB; Katugaha SB
    Transpl Infect Dis; 2020 Aug; 22(4):e13265. PubMed ID: 32077552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.